STOCK TITAN

The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference

The Oncology Institute (NASDAQ: TOI), a leading value-based oncology group in the United States, announced its participation in the upcoming B. Riley's 25th Annual Institutional Investor Conference.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

The Oncology Institute (NASDAQ: TOI), a leading value-based oncology group in the United States, announced its participation in the upcoming B. Riley's 25th Annual Institutional Investor Conference. The event will take place on May 21st, 2025, in Marina Del Rey, CA. The company will be represented by CEO Dr. Daniel Virnich and CFO Rob Carter.

Loading...
Loading translation...
Argus Session date unavailable
-10.57% session move Open Argus
Details

News Market Reaction – TOI

The recorded move for TOI in the trading session of this news was -10.57%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CERRITOS, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in B. Riley’s 25th Annual Institutional Investor Conference in Marina Del Rey, CA on May 21st, 2025.

About The Oncology Institute

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better.

For more information, visit www.theoncologyinstitute.com

Contacts

Media

The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors

Solebury Strategic Communications
investors@theoncologyinstitute.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is The Oncology Institute (TOI) presenting at the B. Riley Conference?

The Oncology Institute will participate in B. Riley's 25th Annual Institutional Investor Conference on May 21st, 2025, in Marina Del Rey, CA.

Who will represent TOI at the B. Riley Institutional Investor Conference?

Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will represent The Oncology Institute at the conference.

What is The Oncology Institute's (TOI) position in the oncology market?

The Oncology Institute is one of the largest value-based oncology groups in the United States.

What is TOI's stock exchange listing?

The Oncology Institute (TOI) is listed on the NASDAQ stock exchange.

Keep reading